Case Updates
U.S. Chamber files coalition amicus brief urging Third Circuit to affirm dismissal of False Claims Act (FCA) suit premised on a fraud-on-the agency theory that would require overriding the Food and Drug Administration's drug approval decisions
August 15, 2024
The brief argues that the suit failed to demonstrate any of the FCA elements of falsity, materiality, or causation.
Douglas Hallward-Driemeier, Kellie Combs, and Beth Weinman of Ropes & Gray LLP served as outside counsel.